Cowen and Company started coverage on shares of Idera Pharmaceuticals (NASDAQ:IDRA) in a research report released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) shares after opening at $4.15 moved to $4.22 on last trade day and at the end of the day closed at $3.88. Company price to sales ratio in past twelve months was calculated as 3774.33 and price to cash ratio as 4.58. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) showed a negative weekly performance of -40.12%.
On March 24, 2014, Organovo Holdings Inc. (NYSEMKT:ONVO) announced that in response to investor inquiries it has updated the “Investor” section of its website, including the section titled “Investor FAQ”. Organovo Holdings Inc. (NYSEMKT:ONVO) shares fell -10.84% in last trading session and ended the day on $7.24. ONVO return on equity ratio is recorded as -134.90% and its return on assets is -113.60%. Organovo Holdings Inc. (NYSEMKT:ONVO) yearly performance is 92.55%.
Princeton-based Advaxis Inc. (NASDAQ:ADXS) announced Wednesday the pricing of a public offering of 4.08 million shares of common stock at $3.00 per share. Advaxis, Inc. (NASDAQ:ADXS) shares moved down -24.82% in last trading session and was closed at $3.06, while trading in range of $2.95 – $3.08. Advaxis, Inc. (NASDAQ:ADXS) year to date (YTD) performance is -27.83%.
On March 18, 2014, Unilife Corporation’s (NASDAQ:UNIS) Chief Financial Officer and Executive Vice President, R. Richard Wieland II, entered into a Separation Agreement and General Release with the Company. Mr. Wieland’s last day of employment with the Company was March 12, 2014. Unilife Corp (NASDAQ:UNIS) weekly performance is -21.42%. On last trading day company shares ended up $4.33. Unilife Corp (NASDAQ:UNIS) distance from 50-day simple moving average (SMA50) is -4.81%. Analysts mean target price for the company is $7.70.